MedPath

Appropriate Dosage of Long-acting Insulin at the Time of Artificial Pancreas Withdrawal

Not Applicable
Conditions
liver cancer, Diabetes
Registration Number
JPRN-UMIN000048787
Lead Sponsor
Okayama Saiseikai General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

Cases of withdrawal from artificial pancreas

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath